Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Non-cash Items: 2023-2025

Historic Non-cash Items for Artiva Biotherapeutics (ARTV) over the last 1 years, with Sep 2025 value amounting to $1.4 million.

  • Artiva Biotherapeutics' Non-cash Items rose 27.48% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 27.48%. This contributed to the annual value of $10.4 million for FY2024, which is 4759.81% up from last year.
  • According to the latest figures from Q3 2025, Artiva Biotherapeutics' Non-cash Items is $1.4 million, which was down 82.82% from $7.9 million recorded in Q2 2025.
  • Artiva Biotherapeutics' 5-year Non-cash Items high stood at $7.9 million for Q2 2025, and its period low was $214,000 during Q4 2023.
  • Moreover, its 3-year median value for Non-cash Items was $1.1 million (2024), whereas its average is $2.1 million.
  • Data for Artiva Biotherapeutics' Non-cash Items shows a peak YoY surged of 430.64% (in 2024) over the last 5 years.
  • Artiva Biotherapeutics' Non-cash Items (Quarterly) stood at $214,000 in 2023, then soared by 430.64% to $1.1 million in 2024, then climbed by 27.48% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $7.9 million for Q2 2025, and $1.1 million during Q1 2025.